Recall of IPLAN RT DOSE

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by BRAINLAB AG.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    22761
  • Event Risk Class
    II
  • Event Initiated Date
    2012-03-12
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Brainlab has become aware of events where the accuracy of the brainlab radiotherapy treatment planning software was not within clinically desirable limits for very small multi-leaf-collimator field sizes which could result in a dose calculation less accurate than the generally accespted standards.

Device

  • Model / Serial
    Model Catalog: 21213F (Lot serial: N/A); Model Catalog: 21213E (Lot serial: N/A); Model Catalog: 21213D (Lot serial: N/A)
  • Product Description
    All Brainlab BrainSCAN and iPlan RT Dose treatment planning software versions
  • Manufacturer

Manufacturer

  • Manufacturer Address
    MUNICH
  • Manufacturer Parent Company (2017)
  • Source
    HC